Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions.

The gut microbiota associated with prediabetes and treatment naïve type 2 diabetes patients

The gut-inhabiting bacteria in pre-type 2 diabetes (pre-T2D) patients.

August 23, 2023

Cresco Labs Q3 Revenue Drops 3% Sequentially

Cresco Labs Reports First Quarter 2023 Results Company remains the #1 seller of branded cannabis products CHICAGO-May 24, 2023-(BUSINESS WIRE)–Cresco Labs Inc. (CSE: CL) (OTCQX:

May 24, 2023

Study finds major gaps in cancer screening use in Federally Qualified Health Centers

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.